Alx Oncology Holdings
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | -0.5% | -52.9% | -74.8% | +570.6% | +144.4% | +4.3% | -19.0% | |
| – | +10.4% | +1,730.3% | +156.0% | +71.3% | +10.2% | +3.1% | -53.6% | |
| – | +10.4% | +2,115.8% | +193.8% | +23.3% | – | – | – | |
| – | – | -94.2% | -1,730.4% | – | -15.8% | -249.8% | – | |
| – | -45.9% | -91.2% | +15,780.6% | -71.0% | -10.7% | -64.9% | -52.6% | |
| – | -45.9% | – | -907.0% | +4,682.0% | – | +93.2% | -4.3% | |
| – | – | – | +91,666.7% | – | – | – | – | |
| – | -100.0% | – | +6,633.3% | +66.3% | +55.7% | -32.9% | -93.2% | |
| – | +0.0% | -210.0% | -95.7% | – | -104.2% | +113.1% | +64.9% | |
| – | +1,535,600.0% | +2,914.1% | -99.5% | +298.9% | +501.3% | -48.0% | -98.8% | |
| – | – | +56,218.1% | -116.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.